## CPRT: Copart, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -5.8% below STRENGTH zone (4.0-10.0%); PEG 2.22 fails VALUE criteria (<1.0); RSI 27 oversold (REVERSION excluded per A/B test). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($36.82)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Marshall Wace LLP Decreases Stock Position in Copart, Inc. $CPRT**
- Source: MarketBeat | 20251209T121415 | Neutral | Relevance: 99%
-  Marshall Wace LLP significantly reduced its stake in Copart, Inc. (NASDAQ:CPRT) by 55.2% in the second quarter, selling over 621,000 shares. This move leaves the fund with 504,296 shares worth approximately $24.75 million. Despite this decrease, several other institutional investors have increased their positions in Copart, and analysts hold a consensus "Hold" rating with an average target price of $47.60.

**2. Burgundy Asset Management Ltd. Sells 453,573 Shares of Copart, Inc. $CPRT**
- Source: MarketBeat | 20251207T100703 | Neutral | Relevance: 98%
-  Burgundy Asset Management Ltd. significantly reduced its stake in Copart, Inc. (NASDAQ:CPRT) by 58.1% in the second quarter, selling 453,573 shares and now owning 327,128 shares valued at $16.05 million. Other institutional investors also adjusted their positions, while analyst ratings on Copart currently show a consensus "Hold" with an average price target of $47.60. Insider selling by CEO Jeffrey Liaw and Director Thomas N. Tryforos has also been reported in recent months.

**3. California Public Employees Retirement System Boosts Stock Position in Copart, Inc. $CPRT**
- Source: MarketBeat | 20251208T094640 | Somewhat-Bullish | Relevance: 97%
-  The California Public Employees Retirement System (CalPERS) significantly increased its stake in Copart, Inc. (NASDAQ:CPRT) by 89% in the second quarter, now holding 2,548,275 shares valued at $125,044,000. Other major institutional investors also raised their positions, leading to institutional investors owning 85.78% of the company. Despite beating EPS estimates, Copart missed on revenue and is trading near its 52-week low, with analysts maintaining a "Hold" rating and a consensus price target of $47.60.

**4. Amundi Sells 5,365,708 Shares of Copart, Inc. $CPRT**
- Source: MarketBeat | 20251208T000806 | Neutral | Relevance: 97%
- Amundi significantly reduced its stake in Copart, Inc. (NASDAQ:CPRT) by 57.2% in the second quarter, selling over 5.3 million shares. Despite this, other major institutional investors like Vanguard, JPMorgan, Geode, and Invesco increased their holdings, and Norges Bank opened a new substantial position, indicating strong overall institutional interest. Wall Street analysts have a consensus "Hold" rating for Copart, with the stock trading near its 52-week low.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-24 | JP Morgan | $45 | $50 | -10% |
| 2025-11-21 | Barclays | $33 | $32 | +3% |
| 2025-11-21 | Baird | $52 | $55 | -5% |
| 2025-11-12 | Barclays | $32 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-24 | JP Morgan | main | Neutral |
| 2025-11-21 | Barclays | main | Underweight |
| 2025-11-21 | Baird | main | Outperform |
| 2025-11-12 | Barclays | init | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($1.19M) |
| Sells | 2 ($10.88M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.3% (+2.4%)
- Blackrock Inc.: 6.5% (-2.4%)
- Principal Financial : 4.2% (+3.2%)
- State Street Corpora: 3.8% (+1.8%)
- JPMORGAN CHASE & CO: 2.7% (+86.7%)

### Key Risks

1. Heavy insider selling: $11M sold (2 transactions in 90 days).
2. Long-term trend broken: trading 22.4% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.22 elevated, pricing in significant growth expectations. Forward P/E 21.3x stretched relative to 10% growth. Quality metrics strong (ROA 11%, margin 34%). Balance sheet: strong liquidity (7.9x), low leverage (D/E 0.10). Analyst sentiment negative (2 target cuts vs 1 raises). Insider selling cluster ($10.9M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.2B |
| Beta | 1.12 |
| 52W Range | $38.18 - $63.85 |
| Short Interest | 3.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.22 |
| Forward P/E | 21.3 |
| Current P/E | 23.4 |
| YoY Growth | 9.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -5.8% (minimal 5-day change). Below STRENGTH zone by 9.8pp (needs >4.0% for momentum thesis). AM_20 at -3.7% indicates price below own 20MA trend. Underperforming sector by 4.3pp, stock-specific weakness. Below SMA200 (0.78x), long-term trend not supportive. RSI oversold at 27, potential bounce setup.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.79% (CS: 12) | Weak |
| RSI_14 | 27.2 | Oversold |
| MACD Histogram | 0.01 | Bullish |
| vs SMA20 | 0.963x | Below |
| vs SMA50 | 0.910x | Below |
| vs SMA200 | 0.776x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $38.44
- **Stop Loss:** $36.82 (4.2% risk)
- **Target:** $40.06 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 308
- **Position Value:** $11,839.52
- **Portfolio %:** 11.84%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-19 (Est: $0.39)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.39 | $0.41 | +5.1% |
| 2025Q3 | $0.36 | $0.41 | +13.3% |
| 2025Q2 | $0.42 | $0.42 | +0.8% |
| 2025Q1 | $0.37 | $0.40 | +7.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*